Literature DB >> 20637863

Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.

Lennart T Mars1, Philippe Saikali, Roland S Liblau, Nathalie Arbour.   

Abstract

Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) characterized by multi-focal demyelination, axonal loss, and immune cell infiltration. Numerous immune mediators are detected within MS lesions, including CD4(+) and CD8(+) T lymphocytes suggesting that they participate in the related pathogenesis. Although CD4(+) T lymphocytes are traditionally considered the main actors in MS immunopathology, multiple lines of evidence suggest that CD8(+) T lymphocytes are also implicated in the pathogenesis. In this review, we outline the recent literature pertaining to the potential roles of CD8(+) T lymphocytes both in MS and its animal models. The CD8(+) T lymphocytes detected in MS lesions demonstrate characteristics of activated and clonally expanded cells supporting the notion that these cells actively contribute to the observed injury. Moreover, several experimental in vivo models mediated by CD8(+) T lymphocytes recapitulate important features of the human disease. Whether the CD8(+) T cells can induce or aggravate tissue destruction in the CNS needs to be fully explored. Strengthening our understanding of the pathogenic potential of CD8(+) T cells in MS should provide promising new avenues for the treatment of this disabling inflammatory disease. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20637863      PMCID: PMC5052066          DOI: 10.1016/j.bbadis.2010.07.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  164 in total

Review 1.  CD8+ T cell effector mechanisms in resistance to infection.

Authors:  J T Harty; A R Tvinnereim; D W White
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

3.  Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

Authors:  Ingunn M Stromnes; Lauren M Cerretti; Denny Liggitt; Robert A Harris; Joan M Goverman
Journal:  Nat Med       Date:  2008-02-17       Impact factor: 53.440

4.  Effects of anti-CD4 antibody treatment on lymphocyte subsets and stimulated tumor necrosis factor alpha production: a study of 29 multiple sclerosis patients entered into a clinical trial of cM-T412.

Authors:  N Llewellyn-Smith; M Lai; D H Miller; P Rudge; A J Thompson; M L Cuzner
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

5.  CD8+ T cell-mediated HLA-A*0201-restricted cytotoxicity to transaldolase peptide 168-176 in patients with multiple sclerosis.

Authors:  Brian Niland; Katalin Banki; William E Biddison; Andras Perl
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

6.  Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes.

Authors:  Julie Cabarrocas; Jan Bauer; Eliane Piaggio; Roland Liblau; Hans Lassmann
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

Review 7.  The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.

Authors:  Alla L Zozulya; Heinz Wiendl
Journal:  Hum Immunol       Date:  2008-08-22       Impact factor: 2.850

Review 8.  Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention.

Authors:  Roland S Liblau; F Susan Wong; Lennart T Mars; Pere Santamaria
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

9.  Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.

Authors:  Alasdair J Coles; D Alastair S Compston; Krzysztof W Selmaj; Stephen L Lake; Susan Moran; David H Margolin; Kim Norris; P K Tandon
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

10.  The relation between inflammation and neurodegeneration in multiple sclerosis brains.

Authors:  Josa M Frischer; Stephan Bramow; Assunta Dal-Bianco; Claudia F Lucchinetti; Helmut Rauschka; Manfred Schmidbauer; Henning Laursen; Per Soelberg Sorensen; Hans Lassmann
Journal:  Brain       Date:  2009-03-31       Impact factor: 13.501

View more
  32 in total

Review 1.  Multiple sclerosis: autoimmunity and viruses.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

2.  Myelin-specific CD8+ T cells exacerbate brain inflammation in CNS autoimmunity.

Authors:  Catriona A Wagner; Pamela J Roqué; Trevor R Mileur; Denny Liggitt; Joan M Goverman
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

3.  B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients.

Authors:  Raphael Schneider; Alma Nazlie Mohebiany; Igal Ifergan; Diane Beauseigle; Pierre Duquette; Alexandre Prat; Nathalie Arbour
Journal:  J Immunol       Date:  2011-09-12       Impact factor: 5.422

Review 4.  Multiple Sclerosis and T Lymphocytes: An Entangled Story.

Authors:  Laurine Legroux; Nathalie Arbour
Journal:  J Neuroimmune Pharmacol       Date:  2015-05-07       Impact factor: 4.147

Review 5.  Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation.

Authors:  B Brooks-Worrell; J P Palmer
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 6.  Modeling the heterogeneity of multiple sclerosis in animals.

Authors:  Sarah B Simmons; Emily R Pierson; Sarah Y Lee; Joan M Goverman
Journal:  Trends Immunol       Date:  2013-05-21       Impact factor: 16.687

7.  The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells.

Authors:  Sarah Y Lee; Joan M Goverman
Journal:  J Immunol       Date:  2013-04-05       Impact factor: 5.422

8.  Blocking initial infiltration of pioneer CD8(+) T-cells into the CNS via inhibition of SHP-2 ameliorates experimental autoimmune encephalomyelitis in mice.

Authors:  Qiong Luo; Yang Sun; Fang-Yuan Gong; Wen Liu; Wei Zheng; Yan Shen; Zi-Chun Hua; Qiang Xu
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

9.  The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis.

Authors:  Jie Lv; Changsheng Du; Wei Wei; Zhiying Wu; Guixian Zhao; Zhenxin Li; Xin Xie
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

10.  Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone.

Authors:  Amy Perrin Ross; Aliza Ben-Zacharia; Colleen Harris; Jennifer Smrtka
Journal:  Front Neurol       Date:  2013-03-08       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.